Cellectis S.A.
CLLS
$2.85
-$0.01-0.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 332.15% | 825.97% | 5,397.35% | 76.24% | -21.12% |
| Total Other Revenue | 8.06% | 1.82% | -8.60% | -13.19% | -19.84% |
| Total Revenue | 223.07% | 351.23% | 435.33% | 46.96% | -20.70% |
| Cost of Revenue | -- | -- | -- | 6.66% | -30.34% |
| Gross Profit | 235.67% | 380.41% | 481.98% | 48.13% | -20.27% |
| SG&A Expenses | 17.74% | 10.21% | 13.52% | 36.03% | 8.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18,540.00% | -910.46% | -383.95% | 83.05% | 99.51% |
| Total Operating Expenses | 1.08% | 1.12% | 3.11% | 16.89% | 2.92% |
| Operating Income | 48.53% | 43.94% | 38.16% | -6.79% | -10.26% |
| Income Before Tax | 26.13% | 27.60% | 68.44% | 15.35% | 27.01% |
| Income Tax Expenses | 232.65% | 142.59% | -100.00% | -212.64% | -199.42% |
| Earnings from Continuing Operations | 25.23% | 27.38% | 68.54% | 16.24% | 27.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.00% | 100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -100.00% | -100.00% |
| Net Income | 25.23% | 7.36% | 63.62% | 1.86% | 18.71% |
| EBIT | 48.53% | 43.94% | 38.16% | -6.79% | -10.26% |
| EBITDA | 57.31% | 51.19% | 44.05% | -7.85% | -12.28% |
| EPS Basic | 48.81% | 41.86% | 78.72% | 36.80% | 42.39% |
| Normalized Basic EPS | 48.98% | 49.97% | 79.96% | 48.02% | 36.50% |
| EPS Diluted | 57.08% | 51.77% | 65.52% | 23.46% | 31.26% |
| Normalized Diluted EPS | 50.01% | 50.90% | 78.66% | 46.70% | 35.19% |
| Average Basic Shares Outstanding | 41.14% | 57.36% | 58.98% | 57.19% | 42.70% |
| Average Diluted Shares Outstanding | 27.08% | 39.75% | 72.71% | 72.21% | 58.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |